Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
dabigatran vs rivaroxaban | 0.44 | 0.7 | 7764 | 56 | 25 |
dabigatran | 0.66 | 1 | 6985 | 61 | 10 |
vs | 1.38 | 0.1 | 1312 | 90 | 2 |
rivaroxaban | 0.17 | 0.2 | 9927 | 76 | 11 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
dabigatran vs rivaroxaban | 1.81 | 1 | 2188 | 50 |
dabigatran vs rivaroxaban mechanism of action | 1.11 | 0.9 | 2031 | 27 |
dabigatran vs apixaban vs rivaroxaban | 0.1 | 0.2 | 6543 | 74 |
switching from dabigatran to rivaroxaban | 0.22 | 0.9 | 7829 | 90 |
dabigatran rivaroxaban and apixaban | 0.84 | 0.4 | 2274 | 98 |
mechanism of action of dabigatran | 1.9 | 0.2 | 6148 | 12 |
mechanism of action of rivaroxaban | 1.91 | 0.4 | 8136 | 94 |
apixaban dabigatran edoxaban and rivaroxaban | 0.31 | 0.4 | 2600 | 66 |
rivaroxaban mode of action | 1.56 | 1 | 6736 | 95 |
mode of action of dabigatran | 0.95 | 0.3 | 7649 | 95 |
dabigatran duration of action | 1.66 | 0.6 | 2993 | 14 |
rivaroxaban duration of action | 1.93 | 0.3 | 1137 | 80 |
rivaroxaban route of administration | 0.82 | 0.9 | 3742 | 4 |
dabigatran route of administration | 1.22 | 1 | 1819 | 52 |
therapeutic response of rivaroxaban | 0.03 | 0.9 | 4994 | 60 |
dual pathway inhibition rivaroxaban | 1.82 | 0.3 | 9278 | 67 |
dabigatran direct thrombin inhibitor | 1.48 | 0.2 | 6266 | 13 |
dabigatran drug interaction case report | 0.25 | 0.2 | 2013 | 36 |
direct thrombin inhibitors dabigatran | 1.53 | 1 | 8841 | 77 |